MedPath

Effects of GnRH agonist for luteal phase support

Phase 2
Conditions
female infertility.
Female infertility
Registration Number
IRCT20110509006420N20
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

age 20-39 years
fresh embryo transfer cycles
HCG -triggered cycles

Exclusion Criteria

Absence of good quality embryo
Ovarian hyper stimulation (more than 18 mature follicles with size more than 14 mm during ovarian stimulation) or estradiol level in trigger days more than 4000 pmol/l
Severe male factor

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: serum BHCG.;Clinical pregnancy. Timepoint: 6 weeks after embryo transfer. Method of measurement: sonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath